Overnight switch from rasagiline to safinamide in parkinson's disease patients with motor fluctuations: A tolerability and safety study.
When switching between MAO-B inhibitors, a 15-day suspension period is a precautionary measure to avoid a serotonin syndrome and hypertensive crises. However, this indication results in a ma...